Adenoviral vector expressing short hairpin RNA targeting Wnt2B has an effective antitumour activity against Wnt2B2-overexpressing tumours

European Journal of Cancer

Volumn 48, Issue 8, 2012, Pages 1208-1218

  Liu, Dage ^a   Kadota, Kyuichi ^a   Ueno, Masaki ^b   Nakashima, Nariyasu ^a   Yokomise, Hiroyasu ^a   Huang, Cheng Long ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

Author keywords

Adenovirus; c Myc; Gene therapy; shRNA; Survivin; Wnt2B

Indexed keywords

ADENOVIRUS VECTOR; ANTINEOPLASTIC AGENT; MYC PROTEIN; PROTEIN WNT2B; RECOMBINANT ADENOVIRAL VECTOR SHWNT2B; RECOMBINANT RNA; SURVIVIN; UNCLASSIFIED DRUG; WNT2 PROTEIN;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GENE THERAPY; CANCER INHIBITION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG CANCER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; CELL LINE, TUMOR; GENE THERAPY; GENES, MYC; GENETIC VECTORS; GLYCOPROTEINS; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MALE; MICE; NEOPLASMS, EXPERIMENTAL; RNA, SMALL INTERFERING; WNT PROTEINS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84860481862     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2011.05.003     Document Type: Article

References (40)

1. D. Herzlinger, J. Qiao, and D. Cohen Induction of kidney epithelial morphogenesis by cells expressing Wnt-1 Dev Biol 166 1994 815 818
2. T.C. Dale Signal transduction by the Wnt family of ligands Biochem J 329 1998 209 223
3. Z. You, D. Saims, and S. Chen Wnt signaling promotes oncogenic transformation by inhibiting c-Myc-induced apoptosis J Cell Biol 157 2002 429 440
4. 2+ pathways Oncogene 18 1999 7860 7872
5. -/- colon carcinoma Science 275 1997 1784 1787
6. T.C. He, A.B. Sparks, and C. Rago Identification of c-MYC as a target of the APC pathway Science 281 1998 1509 1512
7. P.J. Kim, J. Plescia, H. Clevers, E.R. Fearon, and D.C. Altieri Survivin and molecular pathogenesis of colorectal cancer Lancet 362 2003 205 209
8. H. Ma, C. Nguyen, K.S. Lee, and M. Kahn Differential roles for the coactivators CBP and p300 on TCF/β-catenin-mediated survivin gene expression Oncogene 24 2005 3619 3631
9. C.V. Dang, L.M. Resar, and E. Emison Function of the c-Myc oncogenic transcription factor Exp Cell Res 253 1999 63 77
10. M. Zajac-Kaye Myc oncogene: a key component in cell cycle regulation and its implication for lung cancer Lung Cancer 34 2001 S43 S46
11. G. Ambrosini, C. Adida, and D.C. Altieri A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma Nat Med 3 1997 917 921
12. D.C. Altieri Survivin, versatile modulation of cell division and apoptosis in cancer Oncogene 22 2003 8581 8589
13. F. Li, G. Ambrosini, and E.Y. Chu Control of apoptosis and mitotic spindle checkpoint by survivin Nature 396 1998 580 584
14. R.R. Adams, M. Carmena, and W.C. Earnshaw Chromosomal passengers and the (aurora) ABCs of mitosis Trends Cell Biol 11 2001 49 54
15. C. Huang, D. Liu, and S. Ishikawa Wnt1 overexpression promotes tumour progression in non-small cell lung cancer Eur J Cancer 44 2008 2680 2688
16. G. Clement, R. Braunschweig, and N. Pasquier Alterations of the Wnt signaling pathway during the neoplastic progression of Barrett's esophagus Oncogene 25 2006 3084 3092
17. M. Katoh, H. Kirikoshi, and H. Terasaki WNT2B2 mRNA, up-regulated in primary gastric cancer, is a positive regulator of the WNT-beta-catenin-TCF signaling pathway Biochem Biophys Res Commun 289 2001 1093 1098
18. M. Katoh Differential regulation of WNT2 and WNT2B expression in human cancer Int J Mol Med 8 2001 657 660
19. C. Huang, D. Liu, and D. Masuya MRP-1/CD9 gene transduction downregulates Wnt signal pathways Oncogene 23 2004 7475 7483
20. J. Mazieres, L. You, and B. He Wnt2 as a new therapeutic target in malignant pleural mesothelioma Int J Cancer 117 2005 326 332
21. G.J. Hannon RNA interference Nature 418 2002 244 251
22. L. Scherer, and J.J. Rossi RNAi applications in mammalian cells Biotechniques 36 2004 557 561
23. C. Huang, M. Li, C. Chen, and Q. Yao Small interfering RNA therapy in cancer: mechanism, potential targets, and clinical applications Expert Opin Ther Targets 12 2008 637 645
24. T.R. Brummelkamp, R. Bernards, and R. Agami A system for stable expression of short interfering RNAs in mammalian cells Science 296 2002 550 553
25. D.D. Rao, J.S. Vorhies, N. Senzer, and J. Nemunaitis SiRNA vs. shRNA: similarities and differences Adv Drug Deliv Rev 61 2009 746 759
26. W.F. Anderson Human gene therapy Nature 392 1998 25 30
27. R. Vile Cancer gene therapy - new approaches to tumour cell killing J Gene Med 2 2000 141 143
28. V. Keedy, W. Wang, and J. Schiller Phase I study of adenovirus p53 administered by bronchoalveolar lavage in patients with bronchioalveolar cell lung carcinoma: ECOG 6597 J Clin Oncol 26 2008 4166 4171
29. M. Katoh WNT2B: comparative integromics and clinical applications Int J Mol Med 16 2005 1103 1108
30. Y. Kanegae, M. Makimura, and I. Saito A simple and efficient method for purification of infectious recombinant adenovirus Jpn J Med Sci Biol 47 1994 157 166
31. C. Mahotka, T. Krieg, and A. Krieg Distinct in vivo expression patterns of survivin splice variants in renal cell carcinomas Int J Cancer 100 2002 30 36
32. J. Nakano, C. Huang, and D. Liu The clinical significance of splice variants and subcellular localization of survivin in non-small cell lung cancers Br J Cancer 98 2008 1109 1117
33. M. Katoh, M. Hirai, and T. Sugimura Cloning, expression and chromosomal localization of Wnt13, a novel member of the Wnt gene family Oncogene 13 1996 873 876
34. C.S. Rhee, M. Sen, and D. Lu Wnt and frizzled receptors as potential targets for immunotherapy in head and neck squamous cell carcinomas Oncogene 21 2002 6598 6605
35. L. You, B. He, and Z. Xu An anti-Wnt-2 monoclonal antibody induces apoptosis in malignant melanoma cells and inhibits tumor growth Cancer Res 64 2004 5385 5389
36. L. You, B. He, and Z. Xu Inhibition of Wnt-2-mediated signaling induces programmed cell death in non-small-cell lung cancer cells Oncogene 23 2004 6170 6174
37. O. Tetsu, and F. McCormick β-Catenin regulates expression of cyclin D1 in colon carcinomas cells Nature 398 1999 422 426
38. X. Zhang, J.P. Gaspard, and D.C. Chung Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia Cancer Res 61 2001 6050 6054
39. T. Brabletz, A. Jung, S. Dag, F. Hlubek, and T. Kirchner β-Catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer Am J Pathol 155 1999 1033 1038
40. B. Ma, S. Zhang, H. Jiang, B. Zhao, and H. Lv Lipoplex morphologies and their influences on transfection efficiency in gene delivery J Control Release 123 2007 184 194